 |
Newsletters
 |
Radiation Oncology NewsletterFaculty in UCLA’s Department of Radiation Oncology are engaged in a variety of research strategies aiming to improve the ability of radiation therapy to kill cancer cells while sparing healthy tissues. One of the key approaches involves learning more about the effects of radiation on the immune system and using that knowledge to strengthen the effect of the therapy. “The goal is for radiation of the cancer to be able to enhance the immune response by translating radiation-induced cell death into systemic immunity,” explains William H. McBride, D.Sc., the department’s vice chair of basic science research. |
 |
Lung Tumors Treated with Precise High-dose RadiationStereotactic body radiation therapy (SBRT) for lung cancer - similar to stereotactic radiosurgery in the brain and spine - focuses high doses of radiation with extreme precision to treat cancerous tumors in just three to five sessions. Using multiple radiation beams that converge on the target area, physicians are able to safely deliver high doses of radiation with very sharp dose gradients to avoid damaging the surrounding tissue. |
 |
UCLA Department of Radiation Oncology Program UpdateUCLA's Department of Radiation Oncology is committed to patient care and advancing cancer research. Our faculty are innovators in the development and implementation of stateof- the-art technologies and can offer the most advanced treatments to patients whose cancers range from the relatively common - with extensive experience and excellent outcomes in treating prostate, lung and breast cancers - to the most complex and rare oncology cases. |
|
|
High Dose Rate (HDR) BrachyTherapy Publications |
